Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Two Phase 3 Studies in Carcinoid Syndrome

Dillon J, Kulke M, Warner R, Bergsland E, Welin S, O'Dorisio T, Mckee C, Lapuerta P, Pavel ME (2018)

Publication Type: Conference contribution

Publication year: 2018

Journal

Neuroendocrinology Karger

Book Volume: 106

Pages Range: 224-224

Authors with CRIS profile

Marianne Ellen Pavel Professur für Endokrinologie

Involved external institutions

Dana–Farber Cancer Institute

United States (USA) (US) Lexicon Pharmaceuticals, Inc.

United States (USA) (US) University of Iowa

United States (USA) (US) Icahn School of Medicine at Mount Sinai

United States (USA) (US) Uppsala University Hospital / Akademiska sjukhuset

Sweden (SE) University of California San Francisco (UCSF)

United States (USA) (US)

How to cite

APA:

Dillon, J., Kulke, M., Warner, R., Bergsland, E., Welin, S., O'Dorisio, T.,... Pavel, M.E. (2018). Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Two Phase 3 Studies in Carcinoid Syndrome. (pp. 224-224).

MLA:

Dillon, J., et al. "Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Two Phase 3 Studies in Carcinoid Syndrome." 2018. 224-224.

BibTeX: Download